Convergence: Using PREFER as a roadmap for patient preference studies
Regulatory NewsMary Ellen Schneider
BiologicsClinical TrialsEuropeGlobalNorth AmericaPharmaceuticalsRegulatory NewsMary Ellen SchneiderBiologicsClinical TrialsEuropeGlobalNorth AmericaPharmaceuticals